Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 100% increase over the number of companies cited in the previous year.
The citations in the county include:
- Written MDR procedures have not been developed.
- The type and extent of control to be exercised over the product, services and suppliers was not clearly defined.
- Records of acceptable suppliers have not been established.
The companies cited were involved in either Devices or Drugs sectors.
Both companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Ace Products & Consulting, LLC | Drugs | 04/04/2024 | Computer control of master formula records |
Ace Products & Consulting, LLC | Drugs | 04/04/2024 | SOPs not followed / documented |
Ace Products & Consulting, LLC | Drugs | 04/04/2024 | No written record of investigation |
Omega Laboratories, Inc. | Devices | 02/08/2024 | Lack of Written MDR Procedures |
Omega Laboratories, Inc. | Devices | 02/08/2024 | Supplier oversight |
Omega Laboratories, Inc. | Devices | 02/08/2024 | Acceptable supplier records, inadequate records |
Omega Laboratories, Inc. | Devices | 02/08/2024 | Lack of or inadequate procedures |
Omega Laboratories, Inc. | Devices | 02/08/2024 | Lack of or inadequate complaint procedures |